Close

Drug Research

Elis Pharma to present erectile dysfunction drug Vitaros at Dubai event

Elis Pharmaceuticals will present erectile dysfunction drug Vitaros licensed from Apricus Biosciences at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), as part of its pre-launch strategy. Elis Pharmaceuticals received the license...

EyeScience develops new eye vitamin for diabetes patients

EyeScience Labs, a resource in ocular nutrition and maker of EyeScience Macular Health Formula and EyeScience Dry Eye Formula, has developed a new eye vitamin for people with diabetes. The new product called Diabetic...

APP Pharmaceuticals receives marketing approval for Methotrexate Injection

APP Pharmaceuticals, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received FDA approval to market preservative-free Methotrexate Injection, USP. APP worked with the FDA to expedite approval of the oncology drug due to...

Ranbaxy launches cholesterol reducing drug in Australia

Ranbaxy Australia, a subsidiary of Ranbaxy Laboratories, has introduced Atorvastatin 10mg, 20mg, 40mg and 80mg tablets after receiving approval from Therapeutic Goods Administration (TGA) in Australia. The product is launched under the brand name...

La Jolla buys GCS-100 rights from Solana

La Jolla Pharmaceutical Company has acquired global development and commercialization rights to GCS-100 from Solana Therapeutics. GCS-100 is an inhibitor of galectin-3, a novel molecular target implicated in cancer and chronic organ failure. Galectin-3 plays...

Novartis receives Morrison & Foerster advice on Camurus deal

The global law firm, Morrison & Foerster has advised Novartis to sign an exclusive collaboration, option and license agreement with Camurus, a Swedish research-based pharmaceutical company. As per the collaboration, Camurus has granted Novartis...

Mymetics regains intra-nasal influenza vaccine from Solvay

Mymetics, a developer of next-generation preventative vaccines, has regained its intra-nasal influenza vaccine from Solvay.Mymetics has provided license of its intra-nasal flu vaccine, under which Solvay has developed the vaccine until 2008 and also completed phase I trial. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read